Dicalcium phosphate/L-Lysine hydrochloride

磷酸氢钙/盐酸赖氨酸

Report date: 2023/02/16 18:13:20

Base Information

Drug NameDicalcium phosphate/L-Lysine hydrochloride
Drug Alias NameN/A
ClassificationSmall molecules
Mechanisms of ActionCytochrome P450 3A4 inhibitors
TargetsCytochrome P450 3A4
Therapy Area/IndicationsDietary SupplementHypocalcemia
Global Approved IndicationsDietary SupplementHypocalcemia
Approved Indications in ChinaDietary SupplementHypocalcemia
Original Approved Country/TerritoryMainland China
Original Approved Date1985/01/01
Country/TerritoryMainland China
CombinationsYes Dicalcium phosphateL-Lysine hydrochloride
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesHarbin Pharmaceutical Group Sanjing Pharmaceutical No. 4 Factory Co Ltd
Inactive CompaniesN/A
Active IndicationsDietary SupplementHypocalcemia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A